![]() |
|
Any changes to the equipment and processes used to produce a semi-solid dosage form may affect the physicochemical characteristics, bioavailability, and sensory qualities of the final product. The right CDMO should provide expertise and technology from development through scale-up and manufacturing needed to perform the formulation, engineering, analytical testing, and validation work critical for successful site transfer.
|